Article info

Original article
Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study
  1. Correspondence to Dr Jean-Philippe Empana, INSERM U970, Paris Cardiovascular Research Center (PARCC), 56 rue Leblanc, Paris 75015, France; jean-philippe.empana{at}inserm.fr
View Full Text

Citation

Rachas A, Raffaitin C, Barberger-Gateau P, et al
Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study

Publication history

  • Accepted January 31, 2012
  • First published April 14, 2012.
Online issue publication 
July 29, 2016
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.